• Bradford Protein Assay Kit: Technical Guide for Protein Quan

  2026-05-15

  The Bradford Protein Assay Kit (SKU K4103) offers researchers a fast, sensitive, and reproducible method for quantifying protein concentration in solution, particularly in workflows requiring minimal sample and rapid turnaround. It is best suited for routine biochemical protein assays where detergents and interfering substances are absent. The kit is not recommended for absolute quantification of non-BSA proteins or when samples contain agents incompatible with Coomassie dye binding.

• Gramine: Applied Protocols for Ferroptosis Induction in TNBC

  2026-05-15

  Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) offers a targeted approach to induce ferroptosis in triple-negative breast cancer (TNBC) models, leveraging the CUL3–MTDH ubiquitination axis. This article details practical experimental workflows, troubleshooting strategies, and protocol parameters for deploying high-purity Gramine from APExBIO in translational oncology research.

• Honokiol Triggers Paraptosis-Like Death in APL via mTOR/MAPK

  2026-05-14

  This study demonstrates that honokiol induces a caspase-independent, paraptosis-like cell death in acute promyelocytic leukemia (APL) cells by activating mTOR and MAPK signaling pathways. The findings reveal a mechanistic alternative to apoptosis, suggesting potential for novel therapeutic strategies in APL, especially for cases resistant to conventional treatments.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-14

  Schwartz's dissertation introduces a rigorous quantitative framework distinguishing proliferative arrest from cell death in in vitro cancer drug assays. This innovation clarifies the interpretation of anti-proliferative and apoptosis-inducing effects, improving preclinical decision-making and translational relevance.

• Uridine, Trisodium Salt: Enabling RNA-Only Genome Engineerin

  2026-05-13

  Explore how Uridine, Trisodium Salt empowers RNA-only transgene insertion and advanced RNA metabolism studies. This article uniquely analyzes its function in the context of PRINT-mediated genome engineering, offering new insight for nucleoside analog research.

• CB-5083: Applied Workflows for Precision p97 Inhibitor Resea

  2026-05-13

  CB-5083 is powering advanced cancer and protein homeostasis research with unmatched selectivity for p97 inhibition, enabling reproducible workflows from cell-based assays to xenograft models. Discover how to leverage its mechanistic and experimental advantages for robust readouts, protocol troubleshooting, and translational insight.

• U0126-EtOH: Applied MEK1/2 Inhibitor Workflows for MAPK/ERK

  2026-05-12

  U0126-EtOH, a selective MEK1/2 inhibitor from APExBIO, empowers researchers to dissect the MAPK/ERK pathway in models of neuroprotection and inflammation with proven reproducibility. This guide details practical protocols, experimental optimizations, and troubleshooting strategies to maximize data quality in oxidative stress and cell signaling research.

• 2,2,2-Trichloroethanol (SKU C6823): Reliable Protein Analysi

  2026-05-12

  This article explores real-world laboratory scenarios where 2,2,2-Trichloroethanol (SKU C6823) addresses reproducibility, solubility, and workflow reliability challenges in molecular biology research. Drawing on peer-reviewed evidence and best practices, it demonstrates how this small molecule biochemical—supplied by APExBIO—supports robust cell viability, protein analysis, and neurobiology applications.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-05-11

  This study uncovers the WNT5a/GSK3/β-catenin signaling axis as a key regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological inhibition, mass cytometry, and transcriptomics, the authors demonstrate that modulating this pathway limits fat accumulation and enhances muscle regeneration, offering new mechanistic insights for muscle disease research.

• Tubastatin A: Precision HDAC6 Inhibition for Cardiac & Neuro

  2026-05-11

  Explore Tubastatin A, a potent HDAC6 inhibitor, and its emerging roles in safeguarding cardiac and neuronal tissues through selective pathway modulation. This in-depth analysis uniquely connects recent mechanistic insights to practical research protocols.

• AG-120 (Ivosidenib): Unraveling Metabolic Dependencies in ID

  2026-05-10

  Explore how AG-120 (Ivosidenib) goes beyond mutant IDH1 inhibition to target metabolic dependencies in AML. This article uniquely examines CD44-mediated rewiring and assay implications, offering new insights for translational research.

• RHEB Neddylation by UBE2F-SAG Axis Drives mTORC1 in Liver Ca

  2026-05-09

  This study uncovers that RHEB is directly neddylated by the UBE2F-SAG axis, enhancing mTORC1 activity and advancing liver tumorigenesis. The work provides mechanistic clarity on neddylation in hepatocellular carcinoma and identifies the UBE2F-SAG-RHEB axis as a potential therapeutic target.

• Acridine Orange hydrochloride: Technical Guidance for Nuclei

  2026-05-08

  Acridine Orange hydrochloride (SKU B7747) is a dual-fluorescent, cell-permeable dye designed for differential staining of DNA and RNA in cytochemical workflows. This product is best suited for applications such as cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining, but is not intended for long-term solution storage or uses outside established nucleic acid staining protocols. Researchers should consult validated workflows and adhere to product handling guidelines to ensure optimal results.

• Abiraterone Acetate: Applied CYP17 Inhibitor Workflows in Pr

  2026-05-08

  Unlock the full translational power of Abiraterone acetate—an advanced CYP17 inhibitor—across patient-derived 3D models and CRPC assays. This practical guide details workflow enhancements, protocol specifics, and troubleshooting strategies that elevate experimental rigor and reproducibility.

• CDK7 Inhibitor Resistance: Role of Conserved Mutation D97N i

  2026-05-07

  This study uncovers how a conserved mutation (D97N) in CDK7 drives resistance to non-covalent CDK7 inhibitors in cancer cells, while retaining sensitivity to covalent inhibitors. The findings clarify critical aspects of drug resistance mechanisms and inform future design and application of transcription regulation inhibitors in cancer research.

16547 records 1/1104 page Next 12345 下5页 Last page